Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 3)

v3.22.1
STOCKHOLDERS EQUITY (DEFICIT) (Details 3) - Registered Warrant
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Number Of Options Outstanding 2,975,497
Weighted Average Remaining Contractual Life (in Years) 4 years 1 month 20 days
Number Of Exercisable Options 2,975,497
Weighted Average Exercise Price Exercisable | $ / shares $ 5.50
5.50  
Number Of Options Outstanding 2,975,497
Weighted Average Remaining Contractual Life (in Years) 4 years 1 month 20 days
Exercise Price Range, Exercisable 5.50
Number Of Exercisable Options 2,975,497
Weighted Average Exercise Price Exercisable | $ / shares $ 5.50
Exercise Price Range 5.50